Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 190

1.

Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer.

Narasimhulu DM, Bews KA, Hanson KT, Chang YH, Dowdy SC, Cliby WA.

Gynecol Oncol. 2019 Nov 27. pii: S0090-8258(19)31628-2. doi: 10.1016/j.ygyno.2019.11.007. [Epub ahead of print]

PMID:
31785863
2.

Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.

Leitao MM Jr, Zhou QC, Gomez-Hidalgo NR, Iasonos A, Baser R, Mezzancello M, Chang K, Ward J, Chi DS, Long Roche K, Sonoda Y, Brown CL, Mueller JJ, Gardner GJ, Jewell EL, Broach V, Zivanovic O, Dowdy SC, Mariani A, Abu-Rustum NR.

Gynecol Oncol. 2019 Nov 25. pii: S0090-8258(19)31624-5. doi: 10.1016/j.ygyno.2019.11.003. [Epub ahead of print]

PMID:
31780238
3.

Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.

Schlappe BA, Weaver AL, McGree ME, Ducie J, Zahl Eriksson AG, Dowdy SC, Cliby WA, Glaser GE, Abu-Rustum NR, Mariani A, Leitao MM Jr.

Gynecol Oncol. 2019 Nov 24. pii: S0090-8258(19)31623-3. doi: 10.1016/j.ygyno.2019.11.002. [Epub ahead of print]

PMID:
31776037
4.

BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents.

Kanakkanthara A, Kurmi K, Ekstrom TL, Hou X, Purfeerst ER, Heinzen EP, Correia C, Huntoon CJ, O'Brien D, Wahner Hendrickson AE, Dowdy SC, Li H, Oberg AL, Hitosugi T, Kaufmann SH, Weroha SJ, Karnitz LM.

Cancer Res. 2019 Dec 1;79(23):5920-5929. doi: 10.1158/0008-5472.CAN-19-1405. Epub 2019 Oct 16.

PMID:
31619387
5.

Prehabilitation: enhancing the Enhanced Recovery after Surgery pathway.

Kalogera E, Dowdy S.

Int J Gynecol Cancer. 2019 Oct;29(8):1233-1234. doi: 10.1136/ijgc-2019-000887. Epub 2019 Sep 26. No abstract available.

PMID:
31562202
6.

Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer.

Heitz F, Kommoss S, Tourani R, Grandelis A, Uppendahl L, Aliferis C, Burges A, Wang C, Canzler U, Wang J, Belau A, Prader S, Hanker L, Ma S, Ataseven B, Hilpert F, Schneider S, Sehouli J, Kimmig R, Kurzeder C, Schmalfeldt B, Braicu EI, Harter P, Dowdy SC, Winterhoff BJ, Pfisterer J, du Bois A.

Clin Cancer Res. 2019 Sep 16. doi: 10.1158/1078-0432.CCR-19-1741. [Epub ahead of print]

PMID:
31527166
7.

Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer.

Kilts TP, Glaser GE, Langstraat CL, Kumar A, Weaver AL, Mc Gree ME, Gostout BS, Podratz KC, Dowdy SC, Cliby WA, Mariani A, Bakkum-Gamez JN.

Gynecol Oncol. 2019 Oct;155(1):21-26. doi: 10.1016/j.ygyno.2019.08.005. Epub 2019 Aug 10.

PMID:
31409487
8.

A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.

Randall LM, Wenham RM, Low PS, Dowdy SC, Tanyi JL.

Gynecol Oncol. 2019 Oct;155(1):63-68. doi: 10.1016/j.ygyno.2019.07.010. Epub 2019 Jul 27.

PMID:
31362825
9.

Optimizing Preanesthesia Care for the Gynecologic Patient.

Dowdy SC, Kalogera E, Scott M.

Obstet Gynecol. 2019 Aug;134(2):395-408. doi: 10.1097/AOG.0000000000003323.

PMID:
31349358
10.

Improving the rate of surgical normothermia in gynecologic surgery.

Kumar A, Martin DP, Dhanorker SR, Brandt SR, Schroeder DR, Hanson AC, Cima RR, Dowdy SC.

Gynecol Oncol. 2019 Sep;154(3):590-594. doi: 10.1016/j.ygyno.2019.06.027. Epub 2019 Jul 5.

PMID:
31285083
11.

Enhanced Recovery After Surgery and Acute Postoperative Pain Management.

Kalogera E, Dowdy SC.

Clin Obstet Gynecol. 2019 Dec;62(4):656-665. doi: 10.1097/GRF.0000000000000475.

PMID:
31233423
12.

Enhanced recovery after surgery for ovarian cancer.

Dowdy SC.

Clin Adv Hematol Oncol. 2019 Apr;17(4):217-219. No abstract available.

PMID:
31188812
13.

International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery.

Wijk L, Udumyan R, Pache B, Altman AD, Williams LL, Elias KM, McGee J, Wells T, Gramlich L, Holcomb K, Achtari C, Ljungqvist O, Dowdy SC, Nelson G.

Am J Obstet Gynecol. 2019 Sep;221(3):237.e1-237.e11. doi: 10.1016/j.ajog.2019.04.028. Epub 2019 Apr 30.

14.

Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update.

Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, Scott M, Gillis C, Elias K, Wijk L, Huang J, Nygren J, Ljungqvist O, Ramirez PT, Dowdy SC.

Int J Gynecol Cancer. 2019 May;29(4):651-668. doi: 10.1136/ijgc-2019-000356. Epub 2019 Mar 15.

PMID:
30877144
15.

Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions.

Winterhoff B, Kommoss S, Heitz F, Konecny GE, Dowdy SC, Mullany SA, Park-Simon TW, Baumann K, Hilpert F, Brucker S, du Bois A, Schröder W, Burges A, Shen S, Wang J, Tourani R, Ma S, Pfisterer J, Aliferis CF.

AMIA Annu Symp Proc. 2018 Dec 5;2018:1093-1102. eCollection 2018.

16.

Cancer susceptibility gene mutations in type I and II endometrial cancer.

Long B, Lilyquist J, Weaver A, Hu C, Gnanaolivu R, Lee KY, Hart SN, Polley EC, Bakkum-Gamez JN, Couch FJ, Dowdy SC.

Gynecol Oncol. 2019 Jan;152(1):20-25. doi: 10.1016/j.ygyno.2018.10.019. Epub 2018 Oct 26.

PMID:
30612635
17.

A pilot study of non-routine events in gynecological surgery: Type, impact, and effect.

Law KE, Hildebrand EA, Hawthorne HJ, Hallbeck MS, Branaghan RJ, Dowdy SC, Blocker RC.

Gynecol Oncol. 2019 Feb;152(2):298-303. doi: 10.1016/j.ygyno.2018.11.035. Epub 2018 Dec 6.

PMID:
30527338
18.

Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.

Wagner BE, Langstraat CL, McGree ME, Weaver AL, Sarangi S, Mokri B, Dowdy SC, Cliby WA, Kumar A, Bakkum-Gamez JN.

Gynecol Oncol. 2019 Feb;152(2):286-292. doi: 10.1016/j.ygyno.2018.11.021. Epub 2018 Nov 22.

PMID:
30471900
19.

Enhanced Recovery after Minimally Invasive Gynecologic Procedures with Bowel Surgery: A Systematic Review.

Kalogera E, Glaser GE, Kumar A, Dowdy SC, Langstraat CL.

J Minim Invasive Gynecol. 2019 Feb;26(2):288-298. doi: 10.1016/j.jmig.2018.10.016. Epub 2018 Oct 24.

PMID:
30366117
20.

Enhanced recovery after surgery in gynecologic oncology.

Glaser G, Dowdy SC, Peedicayil A.

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:143-146. doi: 10.1002/ijgo.12622.

PMID:
30306585

Supplemental Content

Loading ...
Support Center